medigraphic.com
Colegio de Medicina Interna de México.

2023, Number 4

<< Back Next >>

Med Int Mex 2023; 39 (4)

Red blood cell requirement in a regional hospital in Antioquia, Colombia

Caballero HJD, Martínez SLM, Jaramillo JLI, Lastra GZ, Herrera AL, Vergara YD, Durango SC, Roldán TMD, Vásquez EV

Language: Spanish
References: 15
Page: 623-628
PDF size: 205.82 Kb.


ABSTRACT

Objective: To describe the epidemiological and clinical characteristics of patients who required at least one red blood cell transfusion.
Materials and Methods: A retrospective descriptive study was performed on patients who required at least one red blood cell transfusion at the Santa Fe Hospital in Antioquia, Colombia, during the period 2019-2020. Nonprobabilistic sampling of consecutive cases was performed. Univariate analysis was performed through absolute and relative frequencies (percentages and proportions). Average and standard deviation, median and interquartile ranges were used.
Results: Eighty-nine patients were included in which the female sex predominated with 78.7%, with an average age of 42 years. The main service in which red blood cells were transfused was hospitalization with 57.3%. The most relevant pathological history was anemia with 31.5%. As for the cause of red blood cell requirement, the two main ones were chronic disease (n = 52, 58.4%) and intraoperative bleeding (n = 30, 33.7%). The values of hemoglobin and hematocrit pre and postransfusion were 6.5 and 8.1 g/dL, that is, 20.8 and 24.2%, respectively.
Conclusions: Transfusion was able to show an improvement in hemoglobin and hematocrit values, thus confirming the great benefit for patients. Considering the variables exposed in this study helps to estimate in advance the benefit and safety of this procedure in the hospital setting.


REFERENCES

  1. Espinoza C, Lima Y, Valle C, Núñez M, Calderón A, HidalgoT, et al. Transfusión sanguínea en la práctica clínica eimplicaciones ético-legales. AVFT 2019; 38 (6): 797-803.

  2. Osaro E, Charles AT. The challenges of meeting the bloodtransfusion requirements in Sub-Saharan Africa: the needfor the development of alternatives to allogenic blood. JBlood Med 2011; 2: 7-21. doi: 10.2147/JBM.S17194.

  3. Duits AJ. Challenges for developing sustainable bloodtransfusion services in the Caribbean. ISBT Science Series2013; 8.

  4. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, MurphySA, McCabe CH, et al. Association of hemoglobin levelswith clinical outcomes in acute coronary syndromes.Circulation 2005; 111 (16): 2042-9. doi: 10.1161/01.CIR.0000162477.70955.5F.

  5. Carson JL, Stanworth SJ, Dennis JA, Trivella M, Roubinian N,Fergusson DA, et al. Transfusion thresholds for guiding redblood cell transfusion. Cochrane Database Syst Rev 2021;12 (12): CD002042. doi: 10.1002/14651858.CD002042.

  6. Gil-García EM. Indicaciones de transfusión de hemocomponentes.Hematol Méx 2018; 19 (2): 83-90.

  7. Frazier K, Higgins J, Bugajski, Jones AR, Brown MR. Adversereactions to transfusion of blood products and best practicesfor prevention. Crit Care Nurs Clin North Am 2017; 29(3): 271-90. doi: 10.1016/j.cnc.2017.04.002.

  8. Stokes EA, Wordsworth S, Staves J, Mundy N, Skelly J,Radford K, et al. Accurate costs of blood transfusion: amicrocosting of administering blood products in the UnitedKingdom National Health Service. Transfusion 2018; 58 (4):846-53. doi: 10.1111/trf.14493.

  9. US Department of Health and Human Services, Officeof the Assistant Secretary for Health. Report of the USDepartment of Health and Human Services. The 2009National Blood Collection and Utilization Survey Report.www.hhs.gov/ophs/ bloodsafety/2007nbcus_survey.pdf.

  10. Shander A, Hofmann A, Ozawa S, Theusinger OM, GombotzH, Spahn DR. Activity-based costs of blood transfusions insurgical patients at four hospitals. Transfusion 2010; 50 (4):753-65. doi: 10.1111/j.1537-2995.2009.02518.x.

  11. Cortés A, Botero MP, Llanos G. Sobrevida después detransfusión en pacientes del Hospital Universitario delValle. Colomb Med 2005; 36 (2): 103-9.

  12. Valencia W, Villada I, Calero S, Muñoz D, Varela P, VilladaL. Análisis de la práctica transfusional en un hospital desegundo nivel en Cali, Colombia entre junio y noviembrede 20. Medicas UIS 2012; 25 (2): 107-12.

  13. Meléndez HJ, Zambrano MP, Martínez X. Evaluación de adecuadaindicación transfusional en un hospital universitario.Rev Colomb Anestesiol 2007; 35 (3): 195-201.

  14. Chargoy-Vivaldo E, Quezada-Bolaños S, Cacique-SánchezC. Evaluación de la transfusión de hemoderivados en elHospital Regional Presidente Juárez del ISSSTE, Oaxaca, deacuerdo con la Guía para el uso clínico de la sangre. RevHematol Mex 2014; 15: 174-83.

  15. Quintana-Díaz M, Nanwani-Nanwani K, Marcos-NeiraP, Serrano-Lázaro A, Juarez-Vela R, Andrés-Esteban EM.Epidemiología de la transfusión sanguínea en los Serviciosde Medicina Intensiva en España: “TransfusionDay”. Med Intensiva 2022; 46: 123-31. doi: 10.1016/j.medin.2020.08.015.




2020     |     www.medigraphic.com